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ABSTRACT 
Mycobacterium avium subspecies paratuberculosis (MAP) is an intracellular pathogen 
that is known to parasitize macrophages and monocytes.  MAP infiltrates gastrointestinal tract 
host tissue where it is the known etiological agent of Johne’s disease in ruminants and implicated 
in the etiology of Crohn’s disease in humans.  MAP’s ability to survive within macrophages 
enables it to disseminate throughout the rest of the host, possibly infecting other circulating 
blood leukocytes. In this study, the survival and fate of MAP strain ATCC 43015 (human 
isolate) following phagocytosis was determined using in vitro murine macrophage cell line 
J774A.1 and polymorphonuclear cells (PMNC’s) from five Crohn’s disease patients.  PMNC’s 
from three healthy individuals and two ulcerative colitis patients, as well as Escherichia coli 
(ATCC 11303) and Mycobacterium tuberculosis strain H37Ra (ATCC 25177), were included as 
controls (MOI 10:1).  Maturation of the phagosome was determined by evaluating the presence 
of stage specific markers on the surface of the phagosomal membrane.  The endosomal protein, 
transferrin receptor, and the lysosomal marker, Lamp-1, were then immunostained with Cy-5 
conjugated secondary antibodies, and colocalization of bacteria with each marker was evaluated 
separately using confocal scanning laser microscopy (CSLM).  In both tissue models, 
colocalization of viable MAP and M. tuberculosis with the early endosomal marker, transferrin 
receptor occurred with an estimated five fold higher frequency than did association with the late 
lysosomal marker, Lamp-1, as compared to live E. coli, and all dead bacterial species.  Using 
differential live/dead staining and fluorescent microscopy, survival of M. tuberculosis and MAP 
was estimated at 85% and 79%, respectively compared to only 14% for E. coli.  The outcome 
was similar for both tissue culture and PMNCs from all patients tested, suggesting that MAP and 
ii 
M. tuberculosis can survive readily in both cell types, and regardless of the disease state of the 
host or the killing power of the cell.  MAP’s survival appears to mimic M. tuberculosis’, 
suggesting the ability to resist phagolysosome fusion, by maintaining association with the early 
endosomes.  Overall, the data confirms MAP virulence in host human blood leukocytes. 
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of 
Johne’s disease, and a suspected agent of the inflammatory bowel disease, Crohn’s disease, is a 
slow growing, intracellular pathogen of phagocytic cells (1,2).  While survival mechanisms for 
Mycobacterium tuberculosis have been suggested, MAP’s ability to evade the immune system is 
poorly characterized.  Phagosomal maturation inhibition is one mechanism employed by many 
intracellular pathogens, including M. tuberculosis, to evade the host’s immune response and 
maintain an environment conducive for continued virulence (3).  Although the maturation 
process is not well understood, it is currently accepted that phagosomes mature by entering an 
endosomal like pathway (4).  This is supported by the fact that Rab5 endosomal pathway protein 
and Rab7-GDP late endosomal / lysosomal protein have been detected on the membrane 
phagosomes (4,5).  Therefore, as phagosomes cycle through a cell, they fuse with vesicles from 
the endosomal pathway (6,7).  As a result of this fusion, proteins displayed on the phagosome are 
indicative of what stage endosomes it has bound.  Consequently, the fate of the phagosome 
depends on the array of receptor proteins it displays (6,7).  One important receptor of the early 
endocytic pathway is transferrin receptor (TFR) (8).  Transferrin receptor continually recycles 
between the plasma membrane and early phagosomes, delivering transferrin, and other nutrients, 
to the vesicle.  When transferrin binds to its receptor, it is internalized into the acidic phagosomal 
compartment where bound iron rapidly dissociates.  Due to the iron dependence of mycobacterial 
species, a continued association with this receptor would provide a key nutrient for continued 
survival, as well as an evolutionary advantage for survival within cellular compartments.  
Conversely, if a phagosome proceeds through the maturation process, it fuses with late stage 
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endosomes, then lysosomes and will display lysosomal-associated membrane protein-1 (Lamp-1) 
losing association with early endosomal markers in the process (6,7,8).  Lamp-1 is a stage 
specific protein marker indicative of the formation of the phagolysosome (8,9).  Within the 
phagolysosome, toxic compounds such as acid hydrolases, defensins, nitric oxide, superoxide 
radicals and hypochlorite degrade the phagocytosed bacteria.  Current models of bacterial 
survival in phagolysosomes consider in vitro conditions using hybridoma cells lines, or extracted 
bovine macrophages.  These studies show that MAP, like M. tuberculosis, resists phagosome-
lysosome fusion (10,11).  While the exact methods employed by M. tuberculosis to resist this 
fusion within phagocytes are unknown, one proposed method is mediated by the virulence factor 
mannosylated lipoarabinomannan (ManLAM) (12).  LAMs are lipoglycans that are found only in 
the mycobacterial species (13).  All LAMs are structurally similar, composed of two 
homopolysaccharides that makeup the carbohydrate backbone, D-mannan and D-arabinan, the 
mannan core is terminated by a GPI-anchor, and the arabinan domain is capped by either 
mannosyl (14,15) or phosphoinositol (PI) residues (16,17).  Mannosylated LAMs can be found in 
the pathogenic mycobacterial species M. tuberculosis, M. leprae, M. bovis, and M. avium, while 
PI capped resides are found in the nonpathogenic species M. smegmatis (18-22).  Mycobacterial 
LAMs, in addition to arresting phagosomal maturation (18-22), have also been shown to inhibit 
microbicidal activities of macrophages (23) and neutralize reactive oxygen species (24).  Due to 
virulent mycobacterial species’ ability to survive within macrophages, these bacilli have been 
detected in the periphery of animals as well as humans (2, 25-28).  Recently, MAP was isolated 
and cultured from the blood of patients with Crohn’s disease (2).  These findings raise an 
important question about the ability of blood leukocytes to combat a MAP infection, because 
after subverting the first line defense of tissue macrophages, in a disseminated infection, 
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circulating leukocytes play an important role in host defense (29,30).  Specifically, these cells 
attack invaders extracellularly and within phagocytic vesicles (30).  In this in vivo study, the 
ability of Mycobacterium avium subspecies paratuberculosis to survive within 
polymorphonuclear leukocytes extracted from a healthy individual, an ulcerative colitis patient 
and a Crohn’s disease patient was investigated.     
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CHAPTER TWO: MATERIALS AND METHODOLOGY 
Macrophage cell line 
The mouse macrophage cell line J774A.1 (ATCC TIB-67) was maintained in a 
humidified, 37C, 5% CO2 incubator.  Cells were cultured in DMEM supplemented with 10% 
FCS, 4mM L-glutamine, 4.5 g/l glucose, and 1.5 g/l sodium bicarbonate (ATCC, Rockville, MD, 
USA).  Macrophages were grown until confluent in tissue culture plates, detached from the 
plates using trypsin-EDTA, pelleted by centrifugation, washed twice with PBS and resuspended 
in DMEM containing 10% FCS. The cells were then counted in the presence of trypan blue, 
adjusted to 1x106 viable cells/ml with DMEM containing 10% FCS and distributed in 1ml 
aliquots in 24-well tissue culture plates. 
 
Human PMNCs  
Fresh blood samples assigned with a code were immediately processed in a Biosafety 
Cabinet Class II as follows: PMNCs were isolated using Polymorphoprep density gradient 
separation medium following the manufacturer’s procedure (Greiner Bio One, Inc). Initially, 
blood samples were diluted 1:1 (v/v) with room temperature RPMI culture media (Invitrogen, 
CA).   For PMNCs isolation, a volume of 5ml of the whole blood-RPMI mixture was layered on 
5ml Polymorphoprep solution in 15ml polypropylene tubes.  Tubes were centrifuged at 1,550 
rpm (300g) and room temperature for 30 min. This results in formation of the density gradient 
interface, which is followed by isolation of bands containing PMNCs cells. Purified cells then 
were transferred into sterile tubes for further use.  The polymorphonuclear cells were counted in 
4 
the presence of trypan blue, adjusted to 1x106 viable cells/ml with RMPI + 10% human serum, 
and distributed in 1ml aliquots in 24-well tissue culture plates.   
Bacterial strains and growth conditions  
M. avium subspecies paratuberculosis, (ATCC 43015) was originally obtained from a 
patient.  MAP was grown in flasks containing modified Middlebrook 7H9 broth supplemented 
with mycobactin J and OADC (oleic acid-albumin-dextrose-catalase) in an incubator at 37°C.  
After 4 weeks of growth, the cell concentration was determined using spectroscopic analysis.  M. 
tuberculosis strain H37Ra (ATCC 25177) was grown, and concentration determined, in 
BACTEC bottles in the BACTEC 460 TB Analyzer (Becton Dickinson, Franklin Lake, NJ) as 
described previously (2).  E. coli (ATCC 11303) was grown in LB broth (Miller) in an incubator 
at 37°C.  For all live bacterial samples, aliquots were taken from the cultures and suspended in 
PBS to give a final concentration of 1x107 cells/ml in 1.5ml tubes.   For all dead bacterial 
samples, the remainder of each culture was killed by autoclaving for 20 minutes at 252°F and 20 
psi.  The dead bacteria were then pelleted and suspended in PBS and their concentrations were 
determined using spectroscopic analysis.  Aliquots were then taken and suspended in PBS to 
give a final concentration of 1x107cells/ml. 
Infection of macrophages and human PMNCs for confocal microscopy slides 
All 1ml bacterial aliquots were suspended in FITC at a final concentration of 167µg/ml 
for 30 minutes in the dark.  Bacteria were then washed twice with PBS and finally suspended in 
100µl of RPMI.  Bacterial samples were then added to the cells in the 24-well tissue culture 
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plates with a multiplicity of infection of 10:1.  The cultures or PMNCs with bacteria were then 
incubated for 3 hours in a humidified, 37°C, 5% CO2 incubator 
 
Immunofluorescent labeling  
After the 3 hour infection period, the cells were resuspended by tapping the plate and 
100µl aliquots were allowed to adhere to poly-lysine coated slides (Sigma-Aldrich)  for 30 
minutes in a Biosafety cabinet.  The cells were then fixed with 4% paraformaldehyde for 20 
minutes, rinsed with PBS, and permeabilized with PBS + 0.1% Triton-X 100 for 10 minutes.  
The cells were then incubated with either mouse anti-transferrin receptor or mouse anti-Lamp-1 
primary antibody at a final concentration of 1µg/ml overnight at 4°C (BD Biosciences 
Pharmingen).  Following the incubation, the slides were washed with PBS + 0.1% Triton-X 100 
and incubated with Cy-5 conjugated goat anti-mouse secondary antibody at a 1:100 dilution for 3 
hours at room temperature.  The slides were then rinsed with PBS + 0.1% Triton-X 100, post-
fixed with 4% paraformaldehyde for 10 minutes, rinsed with PBS and allowed to dry under a 
Biosafety cabinet.  Finally, the slides were treated with 1 drop of Vectashield anti-fading 
mounting medium (Vector Laboratories, Burlingame, CA) and coverslipped.   
 
Laser confocal microscopy and colocalization studies  
Images were generated and captured with a Zeiss LSM 510 confocal microscope (Carl 
Zeiss, Inc.) using a 40x objective, equipped with argon (488nm excitation wavelength) and HeNe 
(633 excitation wavelength) lasers.  Bacteria were then viewed as being colocalized with a 
membrane protein (yellow) or noncolocalized (green).   
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Differential live/dead assay - Intracellular survivability  
Polymorphonuclear leukocytes were extracted as described previously, infected with viable 
MAP, M. tuberculosis and E. coli (MOI 10:1) and incubated in 24-well tissue culture plates for 3 
hours in a humidified, 37°C, 5% CO2 incubator.  The cells were then suspended and a 700µl 
aliquot was transferred to a 1.5ml tube.  The samples were then centrifuged for five minutes at 
500g to pellet the leukocytes.  The supernatant was removed and the cells were washed with PBS 
and pelleted twice to remove residual bacteria.  The leukocytes were finally suspended in 800µl 
PBS and lysed with 0.1% deoxycholate (w/v) for five minutes.  The lysate was then incubated 
for 15 minutes with the stains from the live/dead Baclight bacterial viability kit (Molecular 
Probes, Inc., Eugene, OR) as recommended by the manufacturer.  A 30µl sample was then 
mounted and coverslipped.  The bacteria were then counted using a Leica fluorescent microscope 
(40x objective) with a dual band (FITC/TRITC) filter set.  The green fluorescing viable bacteria 
and the red fluorescing dead were counted in each of three fields and shown as an average.  The 
results are expressed as the percentage of live bacteria.   
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CHAPTER FOUR: FINDINGS 
 To evaluate MAP’s ability to resist phagolysosome fusion, we labeled the bacterium with 
FITC and infected tissue culture macrophages and human polymorphonuclear leukocytes for 
three hours.  Slides were prepared and probed with mouse anti-transferrin receptor antibodies to 
evaluate continued association with the early endosomal pathway, or with mouse anti-Lamp-1 
antibodies to evaluate lysosomal fusion.  All slides were immunostained with anti-mouse IgG-
Cy5 secondary antibody.  The bacteria were judged to be colocalized if a yellow signal was 
detected, and judged as not colocalized if the red and green signals could be seen together. 
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Generation of control slides 
The absence of fluorescence in the PMNC without any treatment verifies the fluorescence 
seen in experimental slides is a result of immunostaining and not the auto-fluorescence of other 
cellular proteins as shown in Figure 1.  The absence of red fluorescence in the PMNC treated 
only with FITC labeled bacteria and secondary antibody conjugated to Cy-5 verifies that the 
secondary antibody is not binding non-specifically as shown in Figure 1. 
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Figure 1: Evaluation of auto-fluorescence within PMNCs and non-specific binding of the 
secondary antibody.  PMNCs from a healthy individual with no treatment or Cy-5 conjugated 
goat anti-mouse secondary antibodies and FITC-labeled bacteria for control images visualized 
with confocal microscopy.  (A) PMNC with no immunofluorescent treatment showing no auto-
fluorescence of intracellular structures.  (B) PMNC treated with FITC-labeled MAP and only 
secondary IgG treatment showing no nonspecific binding (no red fluorescence) of the secondary 
IgG-Cy5. CLSM 40x objective. Green fluorescence represents FITC-labeled bacteria. 
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Colocalization of bacteria in tissue culture murine macrophages 
The visible colocalization of live and dead E. coli with Lamp-1 protein indicates that the 
phagosomes containing these bacteria have fused with lysosomes.  Supporting these observations 
is the lack of colocalization with the early endosomal marker, transferrin receptor.  Dead M. 
tuberculosis and dead MAP show similar results shown in Figure 2. 
Colocalization of live M. tuberculosis with the transferrin receptor can be seen, as it can 
with live MAP.  These results, as shown in Figure 2, indicate a continued interaction with the 
early endosomal pathway.  A lack of colocalization with the Lamp-1 protein supports the 
continued association with the early pathway.   
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Figure 2: In vitro survival of MAP, M. tuberculosis and E. coli in tissue culture murine 
macrophages.  
 
 J774 cells treated with FITC-labeled bacteria and indirectly immunostained with primary anti-
TFR or anti-Lamp-1 antibodies and secondary Cy-5 conjugated goat anti-mouse antibodies. (A) 
Infected with viable FITC-labeled E. coli retaining the green signal indicating no colocalization. 
(B) Infected with viable FITC-labeled M. tuberculosis giving a yellow signal indicating 
colocalization. (C) Infected with viable FITC-labeled MAP giving a yellow signal indicating 
colocalization. (D) Infected with viable FITC-labeled E. coli showing a yellow signal indicating 
colocalization. (E) Infected with viable FITC-labeled M. tuberculosis retaining green signal 
indicating no colocalization. (F) Infected with viable FITC-labeled MAP retaining green signal 
indicating no colocalization. (G) Infected with dead FITC-labeled E. coli retaining a green signal 
indicating no colocalization. (H) Infected with dead FITC-labeled M. tuberculosis retaining a 
green signal indicating no colocalization. (I) Infected with dead FITC-labeled MAP retaining a 
green signal indicating no colocalization. (J) Infected with dead FITC-labeled E. coli showing a 
yellow signal indicating colocalization. (K) Infected with dead FITC-labeled M. tuberculosis 
showing a yellow signal indicating colocalization. (L) Infected with dead FITC-labeled MAP 
showing a yellow signal indicating colocalization. CLSM 40x objective. Green fluorescence 
represents FITC-labeled bacteria, red fluorescence represents labeled TFR or Lamp-1, yellow 
fluorescence represents colocalization of bacteria with labeled marker.  Figure images are 
representative of all cells examined. 
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Colocalization of bacteria in healthy PMNCs 
Polymorphonuclear leukocytes from a healthy individual infected with viable FITC-
labeled MAP and viable FITC-labeled M. tuberculosis show colocalization with the transferrin 
receptor, while viable FITC-labeled E. coli and all dead bacteria show colocalization with the 
Lamp-1 marker (Figure 3). 
The visible colocalization of live and dead FITC-labeled E. coli with Lamp-1 protein 
indicates that the phagosomes containing these bacteria have fused with lysosomes.  Supporting 
these observations is the lack of colocalization with the early endosomal marker, transferrin 
receptor.  Dead FITC-labeled M. tuberculosis and dead FITC-labeled MAP show colocalization 
with the Lamp-1 marker (Figure 3). 
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 Figure 3: In vivo survival of MAP, M. tuberculosis and E. coli in healthy PMNCs.   
Healthy individual PMNCs treated with FITC-labeled bacteria indirectly immunostained with 
primary anti-TFR or anti-Lamp-1 antibodies and secondary Cy-5 conjugated goat anti-mouse 
antibodies. (A) Infected with viable FITC-labeled E. coli retaining the green signal indicating no 
colocalization. (B) Infected with viable FITC-labeled M. tuberculosis giving a yellow signal 
indicating colocalization. (C) Infected with viable FITC-labeled MAP giving a yellow signal 
indicating colocalization. (D) Infected with viable FITC-labeled E. coli showing a yellow signal 
indicating colocalization. (E) Infected with viable FITC-labeled M. tuberculosis retaining green 
signal indicating no colocalization. (F) Infected with viable FITC-labeled MAP retaining green 
signal indicating no colocalization. (G) Infected with dead FITC-labeled E. coli retaining a green 
signal indicating no colocalization. (H) Infected with dead FITC-labeled M. tuberculosis 
retaining a green signal indicating no colocalization. (I) Infected with dead FITC-labeled MAP 
retaining a green signal indicating no colocalization. (J) Infected with dead FITC-labeled E. coli 
showing a yellow signal indicating colocalization. (K) Infected with dead FITC-labeled M. 
tuberculosis showing a yellow signal indicating colocalization. (L) Infected with dead FITC-
labeled MAP showing a yellow signal indicating colocalization. CLSM 40x objective. Green 
fluorescence represents FITC-labeled bacteria, red fluorescence represents labeled TFR or 
Lamp-1, yellow fluorescence represents colocalization of bacteria with labeled marker.  
Confocal images are representative of all PMNCs examined for the three healthy individuals. 
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Colocalization of bacteria in Ulcerative Colitis PMNCs  
Ulcerative colitis polymorphonuclear cells infected with viable MAP and viable M. 
tuberculosis show colocalization with the transferrin receptor, indicating continued association 
with early endosomes.  Viable E. coli and all dead bacterial species show colocalization with the 
Lamp-1 marker, a hallmark of phagosome-lysosome fusion. 
The visible colocalization of live and dead E. coli with Lamp-1 protein indicates that the 
phagosomes containing these bacteria have fused with lysosomes.  Supporting these observations 
is the lack of colocalization with the early endosomal marker, transferrin receptor.  Dead M. 
tuberculosis and dead MAP show colocalization with the Lamp-1 marker. 
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Figure 4: In vivo survival of MAP, M. tuberculosis and E. coli in the PMNCs of an ulcerative 
colitis patient.  
 
Ulcerative colitis patient PMNCs treated with FITC-labeled bacteria and indirectly 
immunostained with primary anti-TFR or anti-Lamp-1 antibodies and secondary Cy-5 
conjugated goat anti-mouse antibodies. (A) Infected with viable FITC-labeled E. coli retaining 
the green signal indicating no colocalization. (B) Infected with viable FITC-labeled M. 
tuberculosis giving a yellow signal indicating colocalization. (C) Infected with viable FITC-
labeled MAP giving a yellow signal indicating colocalization. (D) Infected with viable FITC-
labeled E. coli showing a yellow signal indicating colocalization. (E) Infected with viable FITC-
labeled M. tuberculosis retaining green signal indicating no colocalization. (F) Infected with 
viable FITC-labeled MAP retaining green signal indicating no colocalization. (G) Infected with 
dead FITC-labeled E. coli retaining a green signal indicating no colocalization. (H) Infected with 
dead FITC-labeled M. tuberculosis retaining a green signal indicating no colocalization. (I) 
Infected with dead FITC-labeled MAP retaining a green signal indicating no colocalization. (J) 
Infected with dead FITC-labeled E. coli showing a yellow signal indicating colocalization. (K) 
Infected with dead FITC-labeled M. tuberculosis showing a yellow signal indicating 
colocalization. (L) Infected with dead FITC-labeled MAP showing a yellow signal indicating 
colocalization. CLSM 40x objective. Green fluorescence represents FITC-labeled bacteria, red 
fluorescence represents labeled TFR or Lamp-1, yellow fluorescence represents colocalization of 
bacteria with labeled marker.  Confocal images are representative of all PMNCs examined from 
both ulcerative colitis patients. 
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Colocalization of bacteria in Crohn’s disease PMNCs 
In Crohn’s disease polymorphonuclear cells, colocalization of viable MAP and viable M. 
tuberculosis with the transferrin receptor can be seen (Figure 5).  These findings are similar to 
the results of the tissue culture experiment, suggesting that these bacteria can resist intracellular 
degradation in polymorphonuclear leukocytes that have been treated with the host’s serum. 
Conversely, viable E. coli as well as all dead bacteria show colocalization with Lamp-1, 
indicating the phagosomes they reside in fused with lysosomes.   
The visible colocalization of live and dead E. coli with Lamp-1 protein indicates that the 
phagosomes containing these bacteria have fused with lysosomes.  Supporting these observations 
is the lack of colocalization with the early endosomal marker, transferrin receptor.  Dead M. 
tuberculosis and dead MAP show colocalization with the Lamp-1 marker. 
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Figure 5: In vivo survival of MAP, M. tuberculosis and E. coli in the PMNCs of a Crohn’s 
disease patient.  
 
Crohn’s disease patient PMNCs treated with FITC-labeled and indirectly immunostained with 
primary anti-TFR or anti-Lamp-1 antibodies and secondary Cy-5 conjugated goat anti-mouse 
antibodies. (A) Infected with viable FITC-labeled E. coli retaining the green signal indicating no 
colocalization. (B) Infected with viable FITC-labeled M. tuberculosis giving a yellow signal 
indicating colocalization. (C) Infected with viable FITC-labeled MAP giving a yellow signal 
indicating colocalization. (D) Infected with viable FITC-labeled E. coli showing a yellow signal 
indicating colocalization. (E) Infected with viable FITC-labeled M. tuberculosis retaining green 
signal indicating no colocalization. (F) Infected with viable FITC-labeled MAP retaining green 
signal indicating no colocalization. (G) Infected with dead FITC-labeled E. coli retaining a green 
signal indicating no colocalization. (H) Infected with dead FITC-labeled M. tuberculosis 
retaining a green signal indicating no colocalization. (I) Infected with dead FITC-labeled MAP 
retaining a green signal indicating no colocalization. (J) Infected with dead FITC-labeled E. coli 
showing a yellow signal indicating colocalization. (K) Infected with dead FITC-labeled M. 
tuberculosis showing a yellow signal indicating colocalization. (L) Infected with dead FITC-
labeled MAP showing a yellow signal indicating colocalization. CLSM 40x objective. Green 
fluorescence represents FITC-labeled bacteria, red fluorescence represents labeled TFR or 
Lamp-1, yellow fluorescence represents colocalization of bacteria with labeled marker.  
Confocal images are representative of all PMNCs examined from the five Crohn’s disease 
patients. 
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 Intracellular survival of bacteria 
The intracellular survival of MAP and M. tuberculosis compared to E. coli was 
substantially higher (Table 1).  After the three hour infection period, 79% of MAP recovered 
from the lysate of healthy PMNCs was viable as was 85% of the M. tuberculosis.  Conversely, 
only 14% of the E. coli recovered was viable after a three hour infection period.  This 
experiment’s data support colocalization findings that report a greater association of MAP and 
M. tuberculosis with the transferrin receptor compared to E. coli.   
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Table 1: Percent viable E. coli, M. tuberculosis and MAP recovered from healthy PMNC lysate 
after three hour infection. 
 
Microorganism  Percentage of viable bacteria recovered 
 
E. coli    13.9 ± 3.16 
 
M. tuberculosis  84.5 ± 3.22 
 
MAP    79.2 ±_2.08_________________________ 
 
Data expressed as the mean of three microscopic fields. Two standard deviations from the mean 
of the three microscopic fields are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 CHAPTER FIVE: DISCUSSION AND CONCLUSION 
Intracellular mycobacterial pathogens possess several strategies for surviving innate host 
immune responses (31).  The survival of Mycobacterium avium subspecies paratuberculosis 
within phagocytic vesicles depends on its ability to inhibit the maturation process while at the 
same time maintaining access to cellular nutrients.  It has been shown that ManLAM residues on 
the surface of the cell wall of pathogenic mycobacterial species are at least partly responsible for 
these activities, allowing it to overcome host innate immune response (12).  Due to MAP's ability 
to avoid these critical first line defenses, these bacilli have been detected in the breast milk of 
lactating women with Crohn’s disease as well as milk from infected cattle (25,27,28).  Therefore, 
the ability of circulating polymorphonuclear cells to phagocytose and kill MAP becomes of 
critical importance.  The results of the tissue culture experiment are consistent with the findings 
of others’ experiments that show MAP survives intracellular killing by maintaining association 
with the early endosomal pathway (10).  In vitro experiments with tissue culture macrophages 
provide a good model for Mycobacterium avium subspecies paratuberculosis survival.  One 
downfall of these cells is that they have not been activated by IFN-γ or other cytokines.  Cells 
extracted from a Crohn’s disease patient, and incubated with serum, could potentially be 
activated by IFN-γ, although a study showed that macrophages heavily burdened by ManLAM 
were refractory to IFN-γ activation in vitro (23,32).  Consequently, infecting human 
polymorphonuclear cells with MAP provides good insight into this bacterium’s ability to persist 
in the human host after it overcomes the resident tissue macrophages.  Here we show that MAP, 
like M. tuberculosis, is capable of survival within human PMNCs extracted from blood of a 
26 
diagnosed Crohn’s disease patient, an ulcerative colitis patient and a healthy individual, in a 
setting that more closely mimics the natural host environment.  MAP’s ability, like M. 
tuberculosis’, to resist phagosome-lysosome fusion suggests that maybe a similar mechanism is 
at work.  Evidence indicating other intracellular, pathogenic mycobacterial species, including M. 
tuberculosis and M. avium, contain ManLAM residues suggests that MAP could also contain 
mannosylated LAMs (14,24).  If ManLAMs are present at high levels in the MAP cell wall, this 
highly potent virulence factor load could play a role in Crohn’s disease pathogenesis.  
Elucidating the mechanism by which Mycobacterium avium subspecies paratuberculosis 
survives within the phagosomal compartment of host cells could provide insight into treatment 
regimes for both Johne’s and Crohn’s disease. 
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